Abstract
Objective: 1) Investigate the correlation between percentage of metastatic tumor in lymph nodes from patients with squamous cell carcinoma (SCC) of the head and neck and level of expression of 3 marker genes: pemphigus vulgaris antigen (PVA), parathyroid hormone related peptide (PTHrP), and tumor-associated calcium signal transducer (TACSTD1). 2.) Understand the relation of these markers and clinical outcomes.
Method: Four hundred forty-eight grossly negative lymph nodes from 92 patients with SCC were evaluated for expression of the gene markers PVA, PTHrP, and TACSTD1 using real-time PCR. Confirmation of metastasis was determined by histological examination. The expression of these markers was analyzed versus tumor percentage using correlation and linear regression.
Results: All 3 markers were studied independently and were statistically significant predictors of tumor percentage in the lymph nodes at a significance level of 0.05. PVA had the strongest correlation with tumor percent with a correlation coefficient of 0.68, an r squared of 0.46, and a P value <.001. PTHrP had a correlation coefficient of 0.39, r squared of 0.16, and a P value of .003. TACSTD1 had a correlation coefficient of 0.38, r squared of 0.15, and a P value of .004.
Conclusion: All 3 markers are statistically significant predictors of percent tumor in grossly negative lymph nodes. PVA had the strongest correlation. Further analysis will include a multivariate regression to account for possible confounding. Since expression correlates with tumor percent, we expect that expression levels will also correlate with clinical outcomes.
Get full access to this article
View all access options for this article.